Outcome of the vaginal infections and prematurity study: Results of a clinical trial of erythromycin among pregnant women colonized with group B streptococci
- 1 May 1995
- journal article
- clinical trial
- Published by Elsevier in American Journal of Obstetrics and Gynecology
- Vol. 172 (5), 1540-1545
- https://doi.org/10.1016/0002-9378(95)90493-x
Abstract
No abstract availableKeywords
This publication has 18 references indexed in Scilit:
- Early-onset group B streptococcal sepsis: A current assessmentThe Journal of Pediatrics, 1992
- Adjunctive clindamycin therapy for preterm labor: Results of a double-blind, placebo-controlled trialAmerican Journal of Obstetrics and Gynecology, 1991
- A randomized placebo-controlled trial of erythromycin for the treatment of Ureaplasma urealyticum to prevent premature deliveryAmerican Journal of Obstetrics and Gynecology, 1991
- Value of a run-in period in a drug trial during pregnancyControlled Clinical Trials, 1990
- Chlamydia trachomatis infection and pregnancy outcomeAmerican Journal of Obstetrics and Gynecology, 1987
- Prevention of Early-Onset Neonatal Group B Streptococcal Disease with Selective Intrapartum ChemoprophylaxisNew England Journal of Medicine, 1986
- Antimicrobial susceptibility of group B streptococciEuropean Journal of Clinical Microbiology & Infectious Diseases, 1986
- Experience with the Routine Use of Erythromycin for Chlamydial Infections in PregnancyNew England Journal of Medicine, 1986
- Confidence Intervals for the Ratio of Two Binomial ProportionsBiometrics, 1984
- Selective Intrapartum Chemoprophylaxis of Neonatal Group B Streptococcal Early-Onset Disease. II. Predictive Value of Prenatal CulturesThe Journal of Infectious Diseases, 1983